Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: No one is in a hurry to buy it, even at $.055 a share! Not until they see some
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: No one is in a hurry to buy it, even at $.055 a share! Not until they see some
If I was a new investor doing my DD I wouldn't touch PTSC with a ten foot pole. Years ago it looked like it had a great future and a chance for investors to make a huge profit. Now it looks to be the complete opposite. Just my opinion.